AI Collaboration to Streamline Healthcare Administration and Improve Patient Outcomes

1. Treatment.com AI Inc. has a consulting relationship with Street Smart an affiliate of Streetwise Reports. Street Smart Clients pay a monthly consulting fee between US$8,000 and US$20,000.
2. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Treatment.com AI Inc.
3. James Guttman wrote this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor.
4.  This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company. 

For additional disclosures, please click here.

Treatment.com AI Inc. (TRUE:CSE;  TREIF:OTCMKTS; 939:FRA) has formally entered a collaborative agreement with UK-based AI healthcare technology company SPRYT Limited.  This partnership combines Treatment’s proprietary Global Library of Medicine (GLM) with SPRYT’s AI Medical Office Assistant (MOA), Asa, with a goal to enhance patient access and streamline healthcare administration. Asa allows patients to manage medical appointments via messaging apps like WhatsApp. This can be done without needing to download additional software. By integrating Treatment’s GLM, the collaboration seeks to create a first-of-its-kind AI-powered onboarding and triaging tool. This could potentially reduce missed appointments and improve patient outcomes.

According to McKinsey, nearly 25% of the US$4 trillion spent on healthcare in the U.S. is linked to administrative tasks. Missed medical appointments alone cost the U.S. healthcare system approximately US$150 billion annually. SPRYT's integration of Asa with Treatment AI's GLM aims to alleviate these inefficiencies by improving scheduling accuracy and patient engagement.

Treatment.com’s CEO, Dr. Essam Hamza, expressed enthusiasm for the partnership, noting that combining AI with medical history capabilities "has the promise to improve access and outcomes for patients, reduce costs for payers, and greatly reduce administrative burdens."

AI In Healthcare

As Forbes reported on September 18, healthcare AI startups geared towards hospital systems raised US$23.2 billion over the past decade, with US$11.5 billion going to 324 companies focused on solutions impacting clinical care. This influx of venture capital, along with the involvement of tech giants like Microsoft, Amazon, and Apple, has raised questions about whether the industry or regulators will lead the charge in shaping the healthcare AI landscape. Robert Califf, the FDA Commissioner, highlighted concerns about the regulatory challenges, stating that "there is a risk that the system's going to outrun the ability to regulate it, but it will eventually self-correct."

Treatment.com AI's partnership with SPRYT to integrate their Global Library of Medicine (GLM) with SPRYT’s AI-powered Medical Office Assistant, Asa, is part of this larger movement towards using AI to optimize patient care and streamline administrative processes.

McKinsey noted in a September 17 report that administrative tasks account for 25% of the more than US$4 trillion spent annually on healthcare in the United States. By deploying AI solutions, organizations could enhance operational efficiencies and improve consumer experiences. The collaboration between Treatment.com AI and SPRYT reflects this trend, aiming to reduce the inefficiencies that plague healthcare systems by leveraging AI for patient onboarding, triaging, and appointment management.

AI’s potential to revolutionize healthcare is vast, as Appinventiv reported on September 12. Generative AI is "catalyzing a profound transformation within the healthcare industry" by generating synthetic data, predicting patient outcomes, and optimizing treatment plans, all of which revolutionize clinical decision-making processes. This aligns with Treatment.com AI’s goal of integrating Asa with its GLM to enhance patient access to healthcare while reducing administrative burdens.

In a CBC report from September 16, it was written that real-world applications of AI in healthcare are already showing promising results. For example, the AI system Chartwatch led to a 26 percent reduction in unexpected deaths among hospitalized patients. Dr. Muhammad Mamdani, co-author of the study, expressed optimism about AI’s ability to "complement clinicians' own judgment and lead to better outcomes for fragile patients." Treatment.com AI’s collaboration with SPRYT similarly aims to improve patient outcomes by using AI to triage and manage healthcare needs more effectively.

Overall, healthcare organizations are increasingly turning to AI to address both clinical and administrative challenges. The combination of generative AI, as noted by Appinventiv, and operational tools like those developed by Treatment.com AI and SPRYT, are driving this transformation. However, as Forbes noted, regulatory and liability concerns remain critical as the sector continues to evolve. The need for shared accountability across healthcare systems, regulators, and AI developers will be crucial in ensuring that these technologies fulfill their potential while safeguarding patient care.

Treatment.AI's Catalysts

According to the company’s investor presentation, T

reatment.com AI is poised to capitalize on the growing AI healthcare market, which Statista predicts will grow from US$11 billion in 2021 to US$187 billion by 2030. One of the collaboration goals with SPRYT is to contribute to streamlining administrative healthcare tasks and help reduce missed appointments, a major issue that costs billions annually in the U.S. healthcare system. 

Treatment's Global Library of Medicine (GLM) will serve as the backbone for this AI-powered collaboration, providing real-time diagnostic assistance and triaging tools that aim to improve both patient access and healthcare provider efficiency.  

The company’s focus on global markets like North America, the UK, and the Middle East, combined with its AI-driven solutions, presents numerous opportunities for further growth. "The collaboration with SPRYT allows us to explore mutually beneficial commercial applications and solutions," Hamza said. These developments position Treatment.com to enhance its revenue opportunities by addressing some of the biggest inefficiencies in healthcare systems worldwide. 

Ownership and Share Structure

According to Sedi.ca, insiders own approximately 8% of Treatment.com AI.

Retail investors own the remaining 92%. 

As of September 19, 2024, Treatment has 48.33M outstanding common shares and 41,534,555 free float traded shares.

As of September 19, 2024, the market cap is approximately CA$35.77M. Over the past 52 weeks, the company traded between CA$0.19 and CA$1.11 per share.